CLGN - CollPlant Biotechnologies Ltd.

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 85.84M
Enterprise value 62.79M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)126.29
Price/book (mrq)2.87
Enterprise value/revenue 94.28
Enterprise value/EBITDA -3.99

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-13.88%
S&P500 52-week change 36.21%
52-week high 313.97
52-week low 34.27
50-day moving average 37.12
200-day moving average 37.96

Share statistics

Avg vol (3-month) 38.33k
Avg vol (10-day) 310.03k
Shares outstanding 511.38M
Implied shares outstanding 6N/A
Float 8N/A
% held by insiders 110.16%
% held by institutions 112.23%
Shares short (14 May 2023) 417.43k
Short ratio (14 May 2023) 42.98
Short % of float (14 May 2023) 40.21%
Short % of shares outstanding (14 May 2023) 40.15%
Shares short (prior month 13 Apr 2023) 422.81k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 320 Nov 2016
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
Net income avi to common (ttm)N/A
Diluted EPS (ttm)-1.44
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)N/A
Total cash per share (mrq)N/A
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)N/A
Book value per share (mrq)3.00

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A